Dr. Deval Mehta, MD

Dr. Mehta practices at Texas Health Medical Associates in Crowley, Texas.

Dr. Mehta's NPI, 1437376795, was assigned on April 19, 2007. Dr. Mehta graduated from All India Institute of Medical Sciences in 1997. Dr. Mehta holds Texas license N0966.

Dr. Mehta's primary practice is Texas Health Medical Associates, at 901 E Fm-1187, Crowley, TX 76036 in Tarrant County. The practice phone is (817) 568-5467.

Dr. Mehta's primary practice is Texas Health Medical Associates in Crowley, Texas. Dr. Mehta is also affiliated with Texas Health Fort Worth. The medical group on file is Huguley Medical Associates. Dmand AI also links Dr. Mehta to 2 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mehta practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Mehta's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Mehta is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Mehta's licenses on file in 5 states: Texas, California, Alabama, Illinois and Minnesota.

Dmand AI lists angioplasty, cardiac catheterization, leg revascularization, pacemaker or defibrillator implantation and pacemaker replacement among the conditions Dr. Mehta treats.

CMS data shows 4,533 Medicare services from Dr. Mehta across 36 procedure codes in 2024, for 963 Medicare patients. Medicare paid $367,043 for them.

CMS counts 963 Medicare patients who saw Dr. Mehta in 2024. The largest group is 65 to 74, with 408 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mehta's median patient age at 72, with 53% women.

In 2024, Dr. Mehta wrote 6,546 Medicare Part D claims for 963 patients. 84% of them were for generic drugs. CMS names the drug for 6,333 of them, across 47 drugs with 11 or more claims each, at $928,553 in total drug cost. In 2023, CMS named 5,839 claims across 46 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Mehta for performance year 2024, reported individually. Dr. Mehta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mehta as offering telehealth. CMS counts 14 procedures of leg revascularization (restoring blood flow) by Dr. Mehta, more than 70% of the clinicians it reports for that procedure.

Dmand AI links 12 papers to Dr. Mehta, published from 2022 to 2025. The most frequent topics are Tomography, Emission-Computed, Single-Photon, Radiopharmaceuticals and Adenosine. Dr. Mehta has published most often in J Nucl Cardiol. Dr. Mehta's most frequent co-authors are Gurpreet S. Baweja, MD and Rajesh Venkataraman.

CMS Open Payments shows 366 general payments to Dr. Mehta from 45 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 82% of the total. Abbott Laboratories paid the most, $1,834.

Dmand AI lists 2 awards for Dr. Mehta, most recently CMS Stage 1 EHR in 2013.

Dr. Mehta graduated from All India Institute of Medical Sciences in 1997. Dr. Mehta is a member of ACC.

Dr. Mehta is in network with 23 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.